Viewing Study NCT07483827

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-04-01 @ 5:22 PM
Study NCT ID: NCT07483827
Status: RECRUITING
Last Update Posted: 2026-03-19
First Post: 2026-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy
Sponsor: eleva GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None C3 Glomerulopathy (C3G) View
None Healthy Adult Participants View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CPV-104 View
None C3G View
None Complement System View
None kidney disease View
None kidney View
None Factor H View